<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39421150</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2311-2638</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Microbial cell (Graz, Austria)</Title><ISOAbbreviation>Microb Cell</ISOAbbreviation></Journal><ArticleTitle>A complex remodeling of cellular homeostasis distinguishes RSV/SARS-CoV-2 co-infected A549-hACE2 expressing cell lines.</ArticleTitle><Pagination><StartPage>353</StartPage><EndPage>367</EndPage><MedlinePgn>353-367</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15698/mic2024.10.838</ELocationID><Abstract><AbstractText>Concurrent infections with two or more pathogens with analogous tropism, such as RSV and SARS-CoV-2, may antagonize or facilitate each other, modulating disease outcome. Clinically, discrepancies in the severity of symptoms have been reported in children with RSV/SARS-CoV-2 co-infection. Herein, we propose an <i>in vitro</i> co-infection model to assess how RSV/SARS-CoV-2 co-infection alters cellular homeostasis. To this end, A549-hACE2 expressing cells were either infected with RSV or SARS-CoV-2 alone or co-infected with both viruses. Viral replication was assessed at 72 hours post infection by droplet digital PCR, immunofluorescence, and transmission electron microscopy. Anti-viral/receptor/autophagy gene expression was evaluated by RT-qPCR and confirmed by secretome analyses and intracellular protein production. RSV/SARS-CoV-2 co-infection in A549-hACE2 cells was characterized by: 1) an increase in the replication rate of RSV compared to single infection; 2) an increase in one of the RSV host receptors, ICAM1; 3) an upregulation in the expression/secretion of pro-inflammatory genes; 4) a rise in the number and length of cellular conduits; and 5) augmented autophagosomes formation and/or alteration of the autophagy pathway. These findings suggest that RSV/SARS-CoV-2 co-infection model displays a unique and specific viral and molecular fingerprint and shed light on the viral dynamics during viral infection pathogenesis. This in vitro co-infection model may represent a potential attractive cost-effective approach to mimic both viral dynamics and host cellular responses, providing in future readily measurable targets predictive of co-infection progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vanetti</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saulle</LastName><ForeName>Irma</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artusa</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moscheni</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelletti</LastName><ForeName>Gioia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zecchini</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strizzi</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garziano</LastName><ForeName>Micaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenizia</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosoni</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broggiato</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogno</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nebuloni</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clerici</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan Milan Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, Fondazione Don Carlo Gnocchi, IRCCS Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trabattoni</LastName><ForeName>Daria</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limanaqi</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biasin</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan Milan Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Microb Cell</MedlineTA><NlmUniqueID>101632887</NlmUniqueID><ISSNLinking>2311-2638</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Respiratory Syncytial Virus (RSV)</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">cellular homeostasis</Keyword><Keyword MajorTopicYN="N">co-infection</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39421150</ArticleId><ArticleId IdType="pmc">PMC11486504</ArticleId><ArticleId IdType="doi">10.15698/mic2024.10.838</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S, Ruggeberg J U, Willers R, Henrich B, Schroten H, Tenenbaum T. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol. 2010;48(4):239–245. doi: 10.1016/j.jcv.2010.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.05.007</ArticleId><ArticleId IdType="pmc">PMC7185496</ArticleId><ArticleId IdType="pubmed">20646956</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399:2047–2064. doi: 10.1016/S0140-6736(22)00478-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00478-0</ArticleId><ArticleId IdType="pmc">PMC7613574</ArticleId><ArticleId IdType="pubmed">35598608</ArticleId></ArticleIdList></Reference><Reference><Citation>Goka E A, Vallely P J, Mutton K J, Klapper P E. Single and multiple respiratory virus infections and severity of respiratory disease: A systematic review. Paediatr Respir Rev. 2014;15(4):363–370. doi: 10.1016/j.prrv.2013.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2013.11.001</ArticleId><ArticleId IdType="pmc">PMC7106320</ArticleId><ArticleId IdType="pubmed">24361079</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotta M C, Chakr Vcbg, Moura A De, Becker R G, Souza Apd De, Jones M H, Pinto L A, Sarria E E, Pitrez P M, Stein R T, Mattiello R. Respiratory viral coinfection and disease severity in children: A systematic review and meta-analysis. J Clin Virol. 2016;80:45–56. doi: 10.1016/j.jcv.2016.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.04.019</ArticleId><ArticleId IdType="pmc">PMC7185664</ArticleId><ArticleId IdType="pubmed">27155055</ArticleId></ArticleIdList></Reference><Reference><Citation>Asner S A, Science M E, Tran D, Smieja M, Merglen A, Mertz D. Clinical Disease Severity of Respiratory Viral Co-Infection versus Single Viral Infection: A Systematic Review and Meta-Analysis. PLOS ONE. 2014;9(6):99392. doi: 10.1371/journal.pone.0099392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099392</ArticleId><ArticleId IdType="pmc">PMC4059637</ArticleId><ArticleId IdType="pubmed">24932493</ArticleId></ArticleIdList></Reference><Reference><Citation>Asner S A, Rose W, Petrich A, Richardson S, Tran D J. Is virus coinfection a predictor of severity in children with viral respiratory infections? Clin Microbiol Infect. 2015;21(3) doi: 10.1016/j.cmi.2014.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2014.08.024</ArticleId><ArticleId IdType="pmc">PMC7128494</ArticleId><ArticleId IdType="pubmed">25596778</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu Dkw, Pan Y, Cheng Sms, Hui Kpy, Krishnan P, Liu Y, Ng Dym, Wan Ckc, Yang P, Wang Q, Peiris M, Poon L L M. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 2020;66(4):549–555. doi: 10.1093/clinchem/hvaa029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa029</ArticleId><ArticleId IdType="pmc">PMC7108203</ArticleId><ArticleId IdType="pubmed">32031583</ArticleId></ArticleIdList></Reference><Reference><Citation>Biological Hca Lung, Network, Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, Worlock K B, Yoshida M, Barnes J L. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J H, Kim J, Hong S P, Choi S Y, Yang M J, Ju Y S, Kim Y T, Kim H M, Rahman M T, Chung M K, Hong S D, Bae H, Lee C-S, G YKoh. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J Clin Invest. 2021;131(13):148517. doi: 10.1172/JCI148517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148517</ArticleId><ArticleId IdType="pmc">PMC8245175</ArticleId><ArticleId IdType="pubmed">34003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y J, et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020;182(2):429–446. doi: 10.1016/j.cell.2020.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.042</ArticleId><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenizia C, Galbiati S, Vanetti C, Vago R, Clerici M, Tacchetti C, Daniele T. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2. Cells. 2021;10(6):1434. doi: 10.3390/cells10061434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061434</ArticleId><ArticleId IdType="pmc">PMC8226513</ArticleId><ArticleId IdType="pubmed">34201214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Sig Transduct Target Ther. 2020;5(1):283. doi: 10.1038/s41392-020-00426-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa L B, Perez L G, Palmeira V A, Cordeiro T Macedo E, Ribeiro V T, Lanza K, Silva A C Simões E. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System. Front Cell Dev Biol. 2020;8:559841. doi: 10.3389/fcell.2020.559841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.559841</ArticleId><ArticleId IdType="pmc">PMC7525006</ArticleId><ArticleId IdType="pubmed">33042994</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilts J, Crozier Twm, Greenwood Ejd, Lehner P J, Wright G J. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep. 2021;11(1):413. doi: 10.1038/s41598-020-80464-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80464-1</ArticleId><ArticleId IdType="pmc">PMC7801465</ArticleId><ArticleId IdType="pubmed">33432067</ArticleId></ArticleIdList></Reference><Reference><Citation>Heppe-Montero M, Walter S, Hernández-Barrera V, Gil-Prieto R, Á Gil-De-Miguel. Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018. BMC Infect Dis. 2022;22(1):315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8969337</ArticleId><ArticleId IdType="pubmed">35361139</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Learn about RSV in Infants and Young Children. 2022. https://www.cdc.gov/rsv/high-risk/infants-young-children.html.  [2023-04-07]. https://www.cdc.gov/rsv/high-risk/infants-young-children.html</Citation></Reference><Reference><Citation>Andeweg S P, Schepp R M, Kassteele J Van De, Mollema L, Berbers G A M, Boven M Van. Population-based serology reveals risk factors for RSV infection in children younger than 5 years. Sci Rep. 2021;11:8953. doi: 10.1038/s41598-021-88524-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88524-w</ArticleId><ArticleId IdType="pmc">PMC8076290</ArticleId><ArticleId IdType="pubmed">33903695</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Xu L, Xie Z. Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus. Front Cell Infect Microbiol. 2022;12:858629. doi: 10.3389/fcimb.2022.858629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.858629</ArticleId><ArticleId IdType="pmc">PMC8913501</ArticleId><ArticleId IdType="pubmed">35281439</ArticleId></ArticleIdList></Reference><Reference><Citation>Battles M B, Mclellan J S. Respiratory syncytial virus entry and how to block it. Nat Rev Microbiol. 2019;17(4):233–245. doi: 10.1038/s41579-019-0149-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-019-0149-x</ArticleId><ArticleId IdType="pmc">PMC7096974</ArticleId><ArticleId IdType="pubmed">30723301</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins P L, B S Graham. Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis. J Virol. 2008;82(5):2040–2055. doi: 10.1128/JVI.01625-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01625-07</ArticleId><ArticleId IdType="pmc">PMC2258918</ArticleId><ArticleId IdType="pubmed">17928346</ArticleId></ArticleIdList></Reference><Reference><Citation>Peebles R S. Pathogenesis of Respiratory Syncytial Virus Infection in the Murine Model. Proc Am Thorac Soc. 2005;2(2):110–115. doi: 10.1513/pats.200501-002AW.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.200501-002AW</ArticleId><ArticleId IdType="pmc">PMC2713314</ArticleId><ArticleId IdType="pubmed">16113477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong B, Deng S, Wang X, Li Y. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis. J Glob Health. 2022;12:5040. doi: 10.7189/jogh.12.05040.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05040</ArticleId><ArticleId IdType="pmc">PMC9480863</ArticleId><ArticleId IdType="pubmed">36112521</ArticleId></ArticleIdList></Reference><Reference><Citation>Halabi K C, Wang H, Leber A L, Sánchez P J, Ramilo O, Mejias A. Respiratory syncytial virus and SARS-CoV-2 coinfections in children. Pediatr Pulmonol. 2022;57(12):3158–3160. doi: 10.1002/ppul.26127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26127</ArticleId><ArticleId IdType="pmc">PMC9538042</ArticleId><ArticleId IdType="pubmed">35997032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Sharma S, Barua S, Tripathi B N, B T Rouse. Virological and Immunological Outcomes of Coinfections. Clin Microbiol Rev. 2018;31(4):111–128. doi: 10.1128/CMR.00111-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00111-17</ArticleId><ArticleId IdType="pmc">PMC6148187</ArticleId><ArticleId IdType="pubmed">29976554</ArticleId></ArticleIdList></Reference><Reference><Citation>Klase Z, Jeang K-T. Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins. Virology. 2013;443:106–112. doi: 10.1016/j.virol.2013.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.04.027</ArticleId><ArticleId IdType="pmc">PMC3728900</ArticleId><ArticleId IdType="pubmed">23747197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavada J. The Pseudotypic Paradox. J Gen Virol. 1982;63(1):15–24. doi: 10.1099/0022-1317-63-1-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-63-1-15</ArticleId><ArticleId IdType="pubmed">6757385</ArticleId></ArticleIdList></Reference><Reference><Citation>Haney J, Vijayakrishnan S, Streetley J, Dee K, Goldfarb D M, Clarke M, Mullin M, Carter S D, Bhella D, Murcia P R. Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles. Nat Microbiol. 2022;7(11):1879–1890. doi: 10.1038/s41564-022-01242-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01242-5</ArticleId><ArticleId IdType="pubmed">36280786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita T, Watanabe K, Sakurai Y, Nishi K, Yoshikawa R, J Yasuda. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep. 2021;11(1):21259. doi: 10.1038/s41598-021-00809-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00809-2</ArticleId><ArticleId IdType="pmc">PMC8553868</ArticleId><ArticleId IdType="pubmed">34711897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A J, Lee Ac-Y, Chan Jf-W, Liu F, Li C, Chen Y, Chu H, Lau S-Y, Wang P, Chan Cc-S, Poon Vk-M, Yuan S, To Kk-W, Chen H, Yuen K-Y. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters. Clin Infect Dis. 2021;72(12):978–992. doi: 10.1093/cid/ciaa1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1747</ArticleId><ArticleId IdType="pmc">PMC7717201</ArticleId><ArticleId IdType="pubmed">33216851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E-H, Nguyen T-Q, Casel M A B, Rollon R, Kim S-M, Kim Y-I, Yu K-M, Jang S-G, J Yang, Poo H, Jung J U, Choi Y K. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4 + T Cell Responses. J Virol. 2022;96(6):1873–1894. doi: 10.1128/jvi.01873-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01873-21</ArticleId><ArticleId IdType="pmc">PMC8941868</ArticleId><ArticleId IdType="pubmed">35107382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L, Zhao Y, Dong J, Liang S, Guo M, Liu X, Wang X, Huang Z, Sun X, Zhang Z, Dong L, Liu Q, Zheng Y, Niu D, Xiang M, Song K, Ye J, Zheng W, Tang Z, Tang M, Zhou Y, Shen C, Dai M, Zhou L, Chen Y, Yan H, Lan K, Xu K. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 2021;31(4):395–403. doi: 10.1038/s41422-021-00473-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00473-1</ArticleId><ArticleId IdType="pmc">PMC7890106</ArticleId><ArticleId IdType="pubmed">33603116</ArticleId></ArticleIdList></Reference><Reference><Citation>Achdout H, Vitner E B, Politi B, Melamed S, Yahalom-Ronen Y, Tamir H, Erez N, R Avraham, Weiss S, L Cherry, E Bar-Haim, E Makdasi, D Gur, M Aftalion, T Chitlaru, Y Vagima, N Paran, Israely T. Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity. Nat Commun. 2021;12(1):5819. doi: 10.1038/s41467-021-26113-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26113-1</ArticleId><ArticleId IdType="pmc">PMC8492774</ArticleId><ArticleId IdType="pubmed">34611155</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruchhagen C, Krüchten A Van, Klemm C, Ludwig S, Ehrhardt C. In Vitro Models to Study Influenza Virus and Staphylococcus aureus Super-Infection on a Molecular Level. In: Y Yamauchi., editor. Influenza Virus. Springer; New York, New York, NY: 2018. pp. 375–386.</Citation><ArticleIdList><ArticleId IdType="pubmed">30151583</ArticleId></ArticleIdList></Reference><Reference><Citation>Menachery V D, Eisfeld A J, Schäfer A, Josset L, Sims A C, Proll S, Fan S, Li C, Neumann G, Tilton S C, Chang J, Gralinski L E, Long C, Green R, Williams C M, Weiss J, Matzke M M, Webb-Robertson B-J, Schepmoes A A, Shukla A K, Metz T O, Smith R D, Waters K M, Katze M G, Kawaoka Y, Baric R S. Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses. mBio. 2014;5(3):1174–1188. doi: 10.1128/mBio.01174-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01174-14</ArticleId><ArticleId IdType="pmc">PMC4030454</ArticleId><ArticleId IdType="pubmed">24846384</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo E, Holland J J. RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVAL. Annu Rev Microbiol. 1997;51(1):151–178. doi: 10.1146/annurev.micro.51.1.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.51.1.151</ArticleId><ArticleId IdType="pubmed">9343347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wargo A R, Kurath G. Viral fitness: definitions, measurement, and current insights. Current Opinion in Virology. 2012;2(5):538–545. doi: 10.1016/j.coviro.2012.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.07.007</ArticleId><ArticleId IdType="pmc">PMC7102723</ArticleId><ArticleId IdType="pubmed">22986085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehedi M, Mccarty T, Martin S E, Nouën C Le, Buehler E, Chen Y-C, Smelkinson M, Ganesan S, Fischer E R, Brock L G, Liang B, Munir S, Collins P L, Buchholz U J. Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus Spread. PLoS Pathog. 2016;12(12):e1006062. doi: 10.1371/journal.ppat.1006062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006062</ArticleId><ArticleId IdType="pmc">PMC5142808</ArticleId><ArticleId IdType="pubmed">27926942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulloa L, Serra R, Asenjo A, Villanueva N. Interactions between cellular actin and human respiratory syncytial virus (HRSV) Virus Res. 1998;53(1):13–25. doi: 10.1016/S0168-1702(97)00121-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(97)00121-4</ArticleId><ArticleId IdType="pubmed">9617766</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson P C D, Thorburn F, Wissmann B Von, Reynolds A, Mcmenamin J, Gunson R N, Murcia P R. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci. 2019;116(52):27142–27150. doi: 10.1073/pnas.1911083116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1911083116</ArticleId><ArticleId IdType="pmc">PMC6936719</ArticleId><ArticleId IdType="pubmed">31843887</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheemarla N R, Watkins T A, Mihaylova V T, Wang B, Zhao D, Wang G, Landry M L, Foxman E F. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. J Exp Med. 2021;218(8):e20210583. doi: 10.1084/jem.20210583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210583</ArticleId><ArticleId IdType="pmc">PMC8210587</ArticleId><ArticleId IdType="pubmed">34128960</ArticleId></ArticleIdList></Reference><Reference><Citation>Meskill S D, Revell P A, Chandramohan L, Cruz A T. Prevalence of co-infection between respiratory syncytial virus and influenza in children. Am J Emerg Med. 2017;35(3):495–498. doi: 10.1016/j.ajem.2016.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2016.12.001</ArticleId><ArticleId IdType="pubmed">28012809</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris D R, Qu Y, Thomason K S, Mello A Haas De, Preble R, Menachery V D, Casola A, Garofalo R P. The impact of RSV/SARS-CoV-2 co-infection on clinical disease and viral replication: insights from a BALB/c mouse model. bioRxiv. 2023 doi: 10.1101/2023.05.24.542043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.05.24.542043</ArticleId></ArticleIdList></Reference><Reference><Citation>Fage C, Hénaut M, Carbonneau J, Piret J, Boivin G. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells. Viruses. 2022;14(2):395. doi: 10.3390/v14020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020395</ArticleId><ArticleId IdType="pmc">PMC8879759</ArticleId><ArticleId IdType="pubmed">35215988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dee K, Schultz V, Haney J, Bissett L A, Magill C, Murcia P R. Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract. The J Infect Dis. 2023;227(12):1396–1406. doi: 10.1093/infdis/jiac494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac494</ArticleId><ArticleId IdType="pmc">PMC10266949</ArticleId><ArticleId IdType="pubmed">36550077</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts N J, Hiscott J, Signs D J. The limited role of the human interferon system response to respiratory syncytial virus challenge: analysis and comparison to influenza virus challenge. Microb Pathog. 1992;12(6):409–414. doi: 10.1016/0882-4010(92)90003-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0882-4010(92)90003-7</ArticleId><ArticleId IdType="pubmed">1522795</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulle I, Vanetti C, Goglia S, Vicentini C, Tombetti E, Garziano M, Clerici M, Biasin M. A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection? Cells. 2020;9(9):1951. doi: 10.3390/cells9091951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9091951</ArticleId><ArticleId IdType="pmc">PMC7563522</ArticleId><ArticleId IdType="pubmed">32847031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Li R, Li Y, Chen J, Feng F, Sun C. Broadly Antiviral Activities of TAP1 through Activating the TBK1-IRF3-Mediated Type I Interferon Production. IJMS. 2021;22(9):4668. doi: 10.3390/ijms22094668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094668</ArticleId><ArticleId IdType="pmc">PMC8125511</ArticleId><ArticleId IdType="pubmed">33925089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain P-O, Schandene L, Casartelli N, Rameix-Welti M-A, Hervé P-L, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, Descamps D, Fix J, Eléouët J-F, Riffault S, Schwartz O, Porcheray F, Mascart F, Mouquet H, Zhang X, Tissières P, Lo-Man R. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity. Immunity. 2017;46(2):301–314. doi: 10.1016/j.immuni.2017.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.01.010</ArticleId><ArticleId IdType="pmc">PMC7128247</ArticleId><ArticleId IdType="pubmed">28228284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripp R A, Jones L P, Haynes L M, Zheng H, Murphy P M, Anderson L J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol. 2001;2(8):732–738. doi: 10.1038/90675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/90675</ArticleId><ArticleId IdType="pubmed">11477410</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson S M, Mcnally B A, Ioannidis I, Flano E, Teng M N, Oomens A G, Walsh E E, Peeples M E. Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. 2015;11 doi: 10.1371/journal.ppat.1005318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005318</ArticleId><ArticleId IdType="pmc">PMC4676609</ArticleId><ArticleId IdType="pubmed">26658574</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirkova T, Lin S, Oomens A G P, Gaston K A, Boyoglu-Barnum S, Meng J, Stobart C C, Cotton C U, Hartert T V, Moore M L, Ziady A G, Anderson L J. CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J Gen Virol. 2015;96(9):2543–2556. doi: 10.1099/vir.0.000218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000218</ArticleId><ArticleId IdType="pmc">PMC4635495</ArticleId><ArticleId IdType="pubmed">26297201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallak L K, Spillmann D, Collins P L, Peeples M E. Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection. J Virol. 2000;74(22):10508–10513. doi: 10.1128/JVI.74.22.10508-10513.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.22.10508-10513.2000</ArticleId><ArticleId IdType="pmc">PMC110925</ArticleId><ArticleId IdType="pubmed">11044095</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman S A, Hendry R M, Beeler J A. Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G. J Virol. 1999;73(8):6610–6617. doi: 10.1128/JVI.73.8.6610-6617.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.8.6610-6617.1999</ArticleId><ArticleId IdType="pmc">PMC112745</ArticleId><ArticleId IdType="pubmed">10400758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo P, Chin A A, Tan S, Jeon A H, Ackerley C A, Siu K K, Lee J E, Hegele R G. Identification of RSV Fusion Protein Interaction Domains on the Virus Receptor. Nucleolin. Viruses. 2021;13(2):261. doi: 10.3390/v13020261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020261</ArticleId><ArticleId IdType="pmc">PMC7915953</ArticleId><ArticleId IdType="pubmed">33567674</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyari F, Marchant D, Moraes T J, Duan W, Mastrangelo P, Hegele R G. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med. 2011;17(9):1132–1135. doi: 10.1038/nm.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2444</ArticleId><ArticleId IdType="pubmed">21841784</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths C D, Bilawchuk L M, Mcdonough J E, Jamieson K C, Elawar F, Cen Y, Duan W, Lin C, Song H, Casanova J-L, Ogg S, Jensen L D, Thienpont B, Kumar A, Hobman T C, Proud D, Moraes T J, Marchant D J. IGF1R is an entry receptor for respiratory syncytial virus. Nature. 2020;583(7817):615–619. doi: 10.1038/s41586-020-2369-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2369-7</ArticleId><ArticleId IdType="pubmed">32494007</ArticleId></ArticleIdList></Reference><Reference><Citation>Currier M G, Lee S, Stobart C C, Hotard A L, Villenave R, Meng J, Pretto C D, Shields M D, Nguyen M T, Todd S O, Chi M H, Hammonds J, Krumm S A, Spearman P, Plemper R K, Sakamoto K, Peebles R S, Power U F, Moore M I. EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression. PLoS Pathog. 2016;12(5):e1005622. doi: 10.1371/journal.ppat.1005622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005622</ArticleId><ArticleId IdType="pmc">PMC4859522</ArticleId><ArticleId IdType="pubmed">27152417</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella J, Kolatkar P R, Marlor C W, Greve J M, Rossmann M G. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci. 1998;95(8):4140–4145. doi: 10.1073/pnas.95.8.4140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.8.4140</ArticleId><ArticleId IdType="pmc">PMC22455</ArticleId><ArticleId IdType="pubmed">9539703</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet S, Palmenberg A C, Gern J E. Rhinoviruses and Their Receptors. Chest. 2019;155(5):1018–1025. doi: 10.1016/j.chest.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.12.012</ArticleId><ArticleId IdType="pmc">PMC6533451</ArticleId><ArticleId IdType="pubmed">30659817</ArticleId></ArticleIdList></Reference><Reference><Citation>Behera A K, Matsuse H, Kumar M, Kong X, Lockey R F, Mohapatra S S. Blocking Intercellular Adhesion Molecule-1 on Human Epithelial Cells Decreases Respiratory Syncytial Virus Infection. Biochem Biophys Res Commun. 2001;280(1):188–195. doi: 10.1006/bbrc.2000.4093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.4093</ArticleId><ArticleId IdType="pubmed">11162498</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Norowitz T A, Loeffler J, Norowitz Y M, Kohlhoff S. Ann Clin Lab Sci. 5. Vol. 51. 34686518; 2021. Intracellular Adhesion Molecule-1 (ICAM-1) Levels in Convalescent COVID-19 Serum: A Case Report; pp. 730–734.</Citation><ArticleIdList><ArticleId IdType="pubmed">34686518</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlica P, Yario T A, White S, Wang J, Moss W N, Hui P, Vinetz J M, Steitz J A. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes. Proc Natl Acad Sci. 2021;118(52) doi: 10.1073/pnas.2116668118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116668118</ArticleId><ArticleId IdType="pmc">PMC8719879</ArticleId><ArticleId IdType="pubmed">34903581</ArticleId></ArticleIdList></Reference><Reference><Citation>Paluck A, Osan J, Hollingsworth L, Talukdar S N, Saegh A A, Mehedi M. Role of ARP2/3 Complex-Driven Actin Polymerization in RSV Infection. Pathogens. 2021;11(1):26. doi: 10.3390/pathogens11010026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11010026</ArticleId><ArticleId IdType="pmc">PMC8781601</ArticleId><ArticleId IdType="pubmed">35055974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallewaard N L, Bowen A L, Crowe J E. Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology. 2005;331(1):73–81. doi: 10.1016/j.virol.2004.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2004.10.010</ArticleId><ArticleId IdType="pubmed">15582654</ArticleId></ArticleIdList></Reference><Reference><Citation>Merolli A, Kasaei L, Ramasamy S, Kolloli A, Kumar R, Subbian S, Feldman L C. An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy. Sci Rep. 2022;12(1):3794. doi: 10.1038/s41598-022-07867-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07867-0</ArticleId><ArticleId IdType="pmc">PMC8904465</ArticleId><ArticleId IdType="pubmed">35260703</ArticleId></ArticleIdList></Reference><Reference><Citation>Baselga M, Moreo E, Uranga-Murillo I, Arias M, Junquera C. Ultrastructural analysis and three-dimensional reconstruction of cellular structures involved in SARS-CoV-2 spread. Histochem Cell Biol. 2023;159(1):47–60. doi: 10.1007/s00418-022-02152-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-022-02152-7</ArticleId><ArticleId IdType="pmc">PMC9521873</ArticleId><ArticleId IdType="pubmed">36175690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong P, Agosto L M, Munro J B, Mothes W. Cell-to-cell transmission of viruses. Curr Opin Virol. 2013;3(1):44–50. doi: 10.1016/j.coviro.2012.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.11.004</ArticleId><ArticleId IdType="pmc">PMC3587356</ArticleId><ArticleId IdType="pubmed">23219376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiramel A, Brady N, Bartenschlager R. Divergent Roles of Autophagy in Virus Infection. Cells. 2013;2(1):83–104. doi: 10.3390/cells2010083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells2010083</ArticleId><ArticleId IdType="pmc">PMC3972664</ArticleId><ArticleId IdType="pubmed">24709646</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke P-Y, Chen S S-L. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J Clin Invest. 2011;121(1):37–56. doi: 10.1172/JCI41474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI41474</ArticleId><ArticleId IdType="pmc">PMC3007134</ArticleId><ArticleId IdType="pubmed">21135505</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Jin M, Y Ding, Y Zhang, Y Sun, S Huang, Q Xie, C Xu, Cai W. Hepatitis B virus dampens autophagy maturation via negative regulation of Rab7 expression. BST. 2016;10(4):244–250. doi: 10.5582/bst.2016.01049.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2016.01049</ArticleId><ArticleId IdType="pubmed">27396843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyei G B, Dinkins C, Davis A S, Roberts E, Singh S B, Dong C, Wu L, Kominami E, Ueno T, Yamamoto A, Federico M, Panganiban A, Vergne I, Deretic V. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol. 2009;186(2):255–268. doi: 10.1083/jcb.200903070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200903070</ArticleId><ArticleId IdType="pmc">PMC2717652</ArticleId><ArticleId IdType="pubmed">19635843</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C, Zhuang X, Zhang H, Li Y, Zhu Y, Lu J, Ge C, Cong J, Li T, Li N, Tian M, Jin N, Li X. Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues. J Virol. 2021;95(24):1537–1558. doi: 10.1128/JVI.01537-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01537-21</ArticleId><ArticleId IdType="pmc">PMC8610582</ArticleId><ArticleId IdType="pubmed">34550769</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen N C, et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun. 2021;12(1):3818. doi: 10.1038/s41467-021-24007-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24007-w</ArticleId><ArticleId IdType="pmc">PMC8217552</ArticleId><ArticleId IdType="pubmed">34155207</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao G, Zhao H, Li Y, M Ji, Y Chen, Y Shi, Y Bi, P Wang, Zhang H. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev Cell. 2021;56(4):427–442. doi: 10.1016/j.devcel.2020.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.12.010</ArticleId><ArticleId IdType="pmc">PMC7832235</ArticleId><ArticleId IdType="pubmed">33422265</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Li J, Zeng R, Yang J, Liu J, Zhang Z, Song X, Yao Z, Ma C, Li W, Wang K, Wei L. Respiratory Syncytial Virus Replication Is Promoted by Autophagy-Mediated Inhibition of Apoptosis. J Virol. 2018;92(8):2193–2210. doi: 10.1128/JVI.02193-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02193-17</ArticleId><ArticleId IdType="pmc">PMC5874425</ArticleId><ArticleId IdType="pubmed">29386287</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang J, Xu W, Chen J, Tang Y, Xiong S, Li Y, Zhang H, Li M, Liu Z. Cholesterol-rich lysosomes induced by respiratory syncytial virus promote viral replication by blocking autophagy flux. Nat Commun. 2024;15(1):6311. doi: 10.1038/s41467-024-50711-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-50711-4</ArticleId><ArticleId IdType="pmc">PMC11282085</ArticleId><ArticleId IdType="pubmed">39060258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Dang Q, Unutmaz D, Pathak V K, Maldarelli F, Powell D, Hu W-S. Mechanisms of Nonrandom Human Immunodeficiency Virus Type 1 Infection and Double Infection: Preference in Virus Entry Is Important but Is Not the Sole Factor. J Virol. 2005;79(7):4140–4149. doi: 10.1128/JVI.79.7.4140-4149.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4140-4149.2005</ArticleId><ArticleId IdType="pmc">PMC1061529</ArticleId><ArticleId IdType="pubmed">15767415</ArticleId></ArticleIdList></Reference><Reference><Citation>Hübner W, Mcnerney G P, Chen P, Dale B M, Gordon R E, Chuang Fys, Li X-D, Asmuth D M, Huser T, Chen B K. Quantitative 3D Video Microscopy of HIV Transfer Across T Cell Virological Synapses. Science. 2009;323(5922):1743–1747. doi: 10.1126/science.1167525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1167525</ArticleId><ArticleId IdType="pmc">PMC2756521</ArticleId><ArticleId IdType="pubmed">19325119</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang Q, Chen J, Unutmaz D, Coffin J M, Pathak V K, Powell D, Kewalramani V N, Maldarelli F, Hu W-S. Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci. 2004;101(2):632–637. doi: 10.1073/pnas.0307636100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0307636100</ArticleId><ArticleId IdType="pmc">PMC327199</ArticleId><ArticleId IdType="pubmed">14707263</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung A, Maier R, Vartanian J-P, Bocharov G, Jung V, Fischer U, Meese E, Wain-Hobson S, Meyerhans A. Multiply infected spleen cells in HIV patients. Nature. 2002;418(6894):144. doi: 10.1038/418144a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/418144a</ArticleId><ArticleId IdType="pubmed">12110879</ArticleId></ArticleIdList></Reference><Reference><Citation>Syverton J T, Berry G P. MULTIPLE VIRUS INFECTION OF SINGLE HOST CELLS. J Exp Med. 1947;86(2):145–152. doi: 10.1084/jem.86.2.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.86.2.145</ArticleId><ArticleId IdType="pmc">PMC2135721</ArticleId><ArticleId IdType="pubmed">19871662</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan D, Wodarz D. Modeling multiple infection of cells by viruses: Challenges and insights. Math Biosci. 2015;264:21–28. doi: 10.1016/j.mbs.2015.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mbs.2015.03.001</ArticleId><ArticleId IdType="pmc">PMC4426218</ArticleId><ArticleId IdType="pubmed">25770053</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrow K A, Rich L M, Vanderwall E R, Reeves S R, Rathe J A, White M P, Debley J S. Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures. MPs. 2021;4(1):7. doi: 10.3390/mps4010007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mps4010007</ArticleId><ArticleId IdType="pmc">PMC7839057</ArticleId><ArticleId IdType="pubmed">33430421</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanetti C, Trabattoni D, Stracuzzi M, Amendola A, Fappani C, Rubinacci V, Fenizia C, Gianolio L, Biasin M, Dighera A, Saulle I, Tanzi E, Zuccotti G, Clerici M, Giacomet V. Immunological Characterization of HIV and SARS-CoV-2. Coinfected Young Individuals. Cells. 2021;10(11):3187. doi: 10.3390/cells10113187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113187</ArticleId><ArticleId IdType="pmc">PMC8618616</ArticleId><ArticleId IdType="pubmed">34831410</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>